Rankings
▼
Calendar
HRTX Q1 2016 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
$153M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$16M
Operating Income
-$33M
Net Income
-$33M
EPS (Diluted)
$-0.92
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$33M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$112M
Total Liabilities
$19M
Stockholders' Equity
$93M
Cash & Equivalents
$68M
← FY 2016
All Quarters
Q2 2016 →